×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [3]
吉林大学白求恩第一医... [2]
自动化研究所 [1]
上海大学 [1]
武汉大学 [1]
复旦大学上海医学院 [1]
更多...
内容类型
期刊论文 [12]
发表日期
2021 [1]
2020 [3]
2018 [5]
2017 [2]
2014 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Prognostic value of immune checkpoint molecules in breast cancer
期刊论文
BIOSCIENCE REPORTS, 2020, 卷号: 40
作者:
Fang, Jun
;
Chen, Feng
;
Liu, Dong
;
Gu, Feiying
;
Chen, Zhigang
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2020/10/26
Efficacy and safety of carbon-ion radiotherapy for the malignant melanoma: A systematic review
期刊论文
CANCER MEDICINE, 2020, 页码: 13
作者:
Li, Chengcheng
;
Zhang, Qiuning
;
Li, Zheng
;
Feng, Shuangwu
;
Luo, Hongtao
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/01/13
carbon-ion radiotherapy
malignant melanoma
systematic review
Combination Immunotherapy with Cytotoxic T-Lymphocyte-Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis
期刊论文
MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 3, 页码: 802-811
作者:
Sun, Ting
;
Zhang, Wenjia
;
Li, Yuan
;
Jin, Zhengyu
;
Du, Yang
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2020/04/07
Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
期刊论文
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 卷号: 47, 期号: 2
作者:
Zhao, Yinghao
;
Yang, Wei
;
Huang, Yuanyuan
;
Cui, Ranji
;
Li, Xiangyan
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
Ctla-4
PD-1
Antibody
ipilimumab
Tremelimumab
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 卷号: 6
作者:
Wu, Bin
;
Zhang, Qiang
;
Sun, Jie
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Renal cell carcinoma
Nivolumab
Ipilimumab
Sunitinib
Cost-effectiveness
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
期刊论文
Journal for immunotherapy of cancer, 2018, 卷号: 6, 页码: 124
作者:
Wu Bin[1]
;
Zhang Qiang[2]
;
Sun Jie[3]
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/04/22
Cost-effectiveness
Ipilimumab
Nivolumab
Renal cell carcinoma
Sunitinib
Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes
期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 卷号: 12
作者:
Chen, Peng
;
Chen, Fuchao
;
Zhou, Benhong
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
ipilimumab
sargramostim
efficacy
safety
survival
meta-analysis
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
期刊论文
BMC CANCER, 2018, 卷号: Vol.18
作者:
Surabhi Ranjan
;
Martha Quezado
;
Nancy Garren
;
Lisa Boris
;
Christine Siegel
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/26
CTLA-4
Immune
checkpoint
inhibitors
Immunotherapy
Ipilimumab
iRANO
PD-1
Pseudoprogression
Nivolumab
Primary adrenal malignant melanoma: A case report and review of literature
期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 51
作者:
Jin, Meishan
;
Li, Mingyang
;
Xu, Bo
;
Wang, Chunxi
;
Wang, Xiaoqing
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
adrenal gland
ipilimumab
melanoma
primary
treatment
©版权所有 ©2017 CSpace - Powered by
CSpace